Drug Prices

The insurer Humana claims in a <a href="http://www.courthousenews.com/wp-content/uploads/2019/08/Drug-Prices.pdf"><strong>federal antitrust complaint</strong></a> that Mallinckrodt raised the price of the anti-inflammatory prescription drug Acthar from $40 a vial to more than $39,000 — “one of the most outrageous price-gouging schemes in the history of American medicine.”

LOS ANGELES — The insurer Humana claims in a federal antitrust complaint that Mallinckrodt raised the price of the anti-inflammatory prescription drug Acthar from $40 a vial to more than $39,000 — “one of the most outrageous price-gouging schemes in the history of American medicine.”

Categories / Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.